Frequency of Complete Pathological Response in axilla of breast cancer patients after Neoadjuvant systemic therapy. A cross sectional study

Frequency of Complete Pathological Response in axilla of breast cancer patients after Neoadjuvant systemic therapy. A cross sectional study - NACT pCR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026717

Enrollment

326

Registered

2021-10-13

Start date

2021-05-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BREASTCANCER C50

Interventions

Group 1: Frequency of axillary complete pathological response was calculated in patients who achieve complete response in breast after neo adjuvant chemotherapy to assess if these patients can avoid a

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1- All patients aged above 18 2- Patients with Diagnosed Breast cancer. 3- Patients who achieved complete pathological response after neoadjuvant Chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Patients who got operated outside Aga Khan University Hospital 2. Patients whose specimen histopathology was reported from elsewhere. 3. Patients with incomplete medical records

Design outcomes

Primary

Measure	Time frame
Frequency of Complete Pathological Response in axilla after NACT	—

Secondary

Measure	Time frame
type of Tumor biology which achieve maximum complete pathological response	—

Countries

Pakistan

Contacts

Public ContactSakina Abidi

Aga Khan Hospital

sakina.abidi@aku.edu03003974166

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026